Document is current
Any future updates will be listed below
-
Authors
Garcia-Manteiga, Jose M. https://orcid.org/0000-0002-5481-040X
Rrapaj, Eltjona
Caprioglio, Francesca https://orcid.org/0000-0001-9505-8157
De Marchis, Francesco
Lamarca, Andrea
Colley, Liam S.
Carretta, Angelo
Finocchiaro, Daniela
Mercalli, Francesca
Molinario, Annamaria
Arrigoni, Gianluigi
Boldorini, Renzo
Crippa, Massimo P. https://orcid.org/0000-0003-3214-9670
Mezzapelle, Rosanna https://orcid.org/0000-0002-1271-8998
Bianchi, Marco E. https://orcid.org/0000-0002-5329-6445
-
Funding
Funding for this research was provided by:
Associazione Italiana per la Ricerca sul Cancro (AIRC (MFAG 27415))
Associazione Italiana per la Ricerca sul Cancro (AIRC Accelerator Grant PREDICT MESO (ID24290))
Ministero dell'Istruzione, dell'Università e della Ricerca (Epigen 2)
- License Information
-
More Information
Article History
Received: 16 November 2024
Revised: 4 November 2025
Accepted: 2 December 2025
First Online: 16 December 2025
Competing interests
: MEB is founder and part-owner of HMGBiotech . All other authors declare no potential conflicts of interest.
: The use of all human samples was approved by the ethical committee of IRCCS Ospedale San Raffaele. Name of the ethical approval: PREDICT MESO. All analyses were performed in accordance with the relevant guidelines and regulations.
